Sign in

    PETMED EXPRESS (PETS)

    Q4 2024 Earnings Summary

    Reported on Jun 11, 2024
    Pre-Earnings Price$4.20Last close (Jun 10, 2024)
    Post-Earnings Price$4.17Last close (Jun 12, 2024)
    Price Change
    $-0.03(-0.71%)

    What went well

    • PetMeds is experiencing increasing returning customers and improved conversion rates, driven by their customer care and health specialists who communicate with over 100,000-plus pet families every month.
    • The company is focusing on profitability through cost reductions and efficiencies by consolidating their two businesses to create synergies and reduce redundancies, which is expected to have an immediate impact on operating expenses.
    • Efforts to enhance customer lifetime value and repeatability of purchases by focusing on key metrics like new customer acquisition and retention could drive future growth.

    What went wrong

    • Flat new customer growth: The company reported that new customer growth was relatively flat year-over-year for the quarter, indicating potential difficulties in attracting new customers organically.
    • Reliance on cost reductions for profitability: Management emphasized focusing on profitability through reducing redundancies and cutting operating expenses, which may suggest challenges in achieving growth without cost-cutting measures. ,
    • Lack of transparency in organic performance metrics: The company does not break out metrics for the core business separately from recent acquisitions, making it difficult to assess the organic growth of the base business.

    Q&A Summary

    1. Cost Structure and Profitability
      Q: How should we think about cost structure and growth vs. profitability?
      A: The company is focused on profitability by creating synergies and reducing redundancies through the consolidation of two businesses. They are examining every line item to eliminate duplicated costs from vendors and agencies, which will have an immediate impact on reducing operating expenses. By finding better efficiencies and synergizing the businesses, they aim to enhance profitability.

    2. Core Business Growth
      Q: Have you seen stabilization, and what else is needed for growth?
      A: They are focusing on top vendors and top-performing SKUs, ensuring key medications are always in stock with the help of the Veterinary Advisory Board. The company is seeing an increase in returning customers and an improvement in conversion rates through customer care specialists and online channels. Initiatives are expected to drive top-line growth and margin improvement, moving away from discount pricing to provide true value in services and products.

    3. Organic Growth Metrics
      Q: Can you provide organic growth metrics excluding PetCareRx?
      A: They do not break out the metrics separately but reported that new customer numbers for the quarter were relatively flat compared to last year on a consolidated basis. The focus remains on new customer acquisition, retention, and increasing the lifetime value and repeatability of customers.

    Analyst Coverage

    Research analysts covering PETMED EXPRESS.